State Ledger
Company profile

Phio Pharmaceuticals Corp. CIK 1533040

Ticker
PHIO (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
King Of Prussia, PA 19406
Fiscal year end
2025 (FY)
Market Data
Close
$0.98
Change
-$0.02
Change %
-2.00%
Volume
700

PHIO · trading date Oct 8, 2026 · previous close $1.00 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.70M
Total assets
$21.49M
Total liabilities
$1.34M
Stockholders' equity
$20.15M
Cash & equivalents
$21.03M
Operating income
-$9.22M
Operating cash flow
-$7.98M
Capital expenditures
$12.0K

Fiscal year 2025, via 10-K filed 2026-03-05. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$7.99M
Free cash flow margin
—
Liabilities / assets
6.2%
Equity / assets
93.8%
CapEx / revenue
—
Operating cash flow / net income
0.92×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.70M $21.49M $1.34M $20.15M
2024 — -$7.15M $5.74M $1.02M $4.72M
2023 — -$10.83M $9.36M $1.63M $7.73M
2022 — -$11.48M $12.81M $1.97M $10.84M
2021 — -$13.29M $25.17M $3.24M $21.93M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-16
Financials filed via
Form 10-K
filed 2026-03-05

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
King Of Prussia, PA 19406
411 SWEDELAND ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Pennsylvania — Public Companies